[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.197.66.254. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
news@JAMA
January 15, 2014

From JAMA’s Daily News Site

JAMA. 2014;311(3):234. doi:10.1001/jama.2013.285703

Continuous positive airway pressure (CPAP) appears to be slightly better than intubation for reducing the risk of bronchopulmonary dysplasia in very preterm infants receiving breathing support for respiratory distress syndrome.

Authors of the study concluded that for every 25 babies treated with nasal CPAP rather than being intubated, 1 additional infant could survive to 36 weeks without developing bronchopulmonary dysplasia. They based their conclusion on a meta-analysis of 4 randomized controlled trials involving 2782 preterm infants needing respiratory support. Nearly all infants born before 28 weeks of pregnancy develop respiratory distress syndrome.

First Page Preview View Large
First page PDF preview
First page PDF preview
×